Previous Close | 42.14 |
Open | 42.05 |
Bid | 41.50 x 1100 |
Ask | 0.00 x 800 |
Day's Range | 41.92 - 42.12 |
52 Week Range | 22.89 - 45.76 |
Volume | |
Avg. Volume | 56,055 |
Market Cap | 1.576B |
Beta (5Y Monthly) | 0.61 |
PE Ratio (TTM) | 34.38 |
EPS (TTM) | 1.22 |
Earnings Date | May 21, 2024 - May 27, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Dec 10, 2018 |
1y Target Est | 43.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for TARO
(Bloomberg) -- Hand sanitizers were tainted by benzene. Sunscreens and dry shampoos too. Now acne treatments are joining the list of widely used consumer products found to contain high levels of the chemical linked to cancer.Most Read from BloombergChemical Linked to Cancer Found in Acne Creams Including Proactiv, ClearasilHow Trump’s Ex-Treasury Chief Landed 2024's Highest-Profile US Bank DealNikki Haley Ends 2024 Bid, Setting Up Trump-Biden RematchNew York to Deploy National Guard to NYC Subwa
Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., January 25, 2024--TARO PROVIDES RESULTS FOR DECEMBER 31, 2023